UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Spirit of America Management Corp NY

Spirit of America Management Corp NY reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 17.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,950 shares of the healthcare conglomerate’s stock after selling 400 shares during the period. Spirit of America Management Corp NY’s holdings in UnitedHealth Group were worth $986,000 as of its most recent SEC filing.

Several other institutional investors have also recently modified their holdings of the stock. State Street Corp raised its position in shares of UnitedHealth Group by 1.3% during the 3rd quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate’s stock worth $26,626,387,000 after purchasing an additional 563,554 shares during the last quarter. Geode Capital Management LLC raised its holdings in UnitedHealth Group by 1.6% in the 3rd quarter. Geode Capital Management LLC now owns 19,636,704 shares of the healthcare conglomerate’s stock valued at $11,440,133,000 after acquiring an additional 318,039 shares during the last quarter. Franklin Resources Inc. lifted its stake in shares of UnitedHealth Group by 2.5% during the 3rd quarter. Franklin Resources Inc. now owns 8,061,916 shares of the healthcare conglomerate’s stock worth $4,884,019,000 after purchasing an additional 193,800 shares during the period. International Assets Investment Management LLC lifted its stake in shares of UnitedHealth Group by 78,814.4% during the 3rd quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock worth $3,096,896,000 after purchasing an additional 5,290,025 shares during the period. Finally, Fisher Asset Management LLC lifted its stake in shares of UnitedHealth Group by 3.5% during the 3rd quarter. Fisher Asset Management LLC now owns 3,197,167 shares of the healthcare conglomerate’s stock worth $1,869,320,000 after purchasing an additional 107,097 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the business’s stock in a transaction dated Friday, January 17th. The shares were bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $545.08 on Wednesday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The company’s 50-day simple moving average is $535.03 and its 200-day simple moving average is $565.09. The stock has a market capitalization of $501.63 billion, a price-to-earnings ratio of 35.17, a PEG ratio of 1.48 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. During the same quarter last year, the company posted $5.83 earnings per share. UnitedHealth Group’s revenue was up 6.8% on a year-over-year basis. Equities analysts anticipate that UnitedHealth Group Incorporated will post 29.63 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages have weighed in on UNH. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Wells Fargo & Company dropped their price objective on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Barclays dropped their price objective on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a report on Friday, January 17th. Deutsche Bank Aktiengesellschaft increased their price target on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. Finally, Morgan Stanley lowered their price target on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a report on Wednesday, October 16th. One analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Buy” and a consensus price target of $629.32.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.